Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria-Jose Ribal

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2018
Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam appsCosimo De Nunzio, Riccardo Lombardo, Giorgia Tema, et al.
European Urology|September 5, 2018
Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social MediaHendrik Borgmann, Matthew Cooperberg, Declan Murphy, et al.
The Prostate|June 18, 2024
Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancerJulián Córdoba Sánchez, Inés Monge-Escartín, Javier Gil, et al.
World Journal of Urology|June 26, 2021
Development of a nomogram predicting the probability of stone free rate in patients with ureteral stones eligible for semi-rigid primary laser uretero-litothripsyCosimo De Nunzio, Jamil Ghahhari, Riccardo Lombardo, et al.
EJNMMI Research|December 18, 2024
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancerGary Amseian, Marcel Figueras, Joel Mases, et al.
Cancer Medicine|December 8, 2023
Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patientsJulián Córdoba Sánchez, Natalia Picola, Alejo Rodriguez-Vida, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 23, 2018
Mobile phone apps for the prediction of prostate cancer: External validation of the Coral and Rotterdam appsCosimo De Nunzio, Riccardo Lombardo, Giorgia Tema, et al.
European Urology|September 5, 2018
Online Professionalism-2018 Update of European Association of Urology (@Uroweb) Recommendations on the Appropriate Use of Social MediaHendrik Borgmann, Matthew Cooperberg, Declan Murphy, et al.
The Prostate|June 18, 2024
Real-world study: Impact of multidisciplinary management of apalutamide-associated adverse events in prostate cancerJulián Córdoba Sánchez, Inés Monge-Escartín, Javier Gil, et al.
World Journal of Urology|June 26, 2021
Development of a nomogram predicting the probability of stone free rate in patients with ureteral stones eligible for semi-rigid primary laser uretero-litothripsyCosimo De Nunzio, Jamil Ghahhari, Riccardo Lombardo, et al.
EJNMMI Research|December 18, 2024
cfDNA fragmentation patterns correlate with tumor burden measured via PSMA PET/CT volumetric parameters in patients with biochemical recurrence of prostate cancerGary Amseian, Marcel Figueras, Joel Mases, et al.
Cancer Medicine|December 8, 2023
Apalutamide for prostate cancer: Multicentre and multidisciplinary real-world study of 227 patientsJulián Córdoba Sánchez, Natalia Picola, Alejo Rodriguez-Vida, et al.
Pageof 2